Aimmune Therapeutics Announces COO Howard Raff To Be Replaced By: Benzinga via Benzinga October 09, 2015 at 09:01 AM EDT Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing desensitization treatments for food allergies, today ... Read More >> Related Stocks: Aimmune Therap